Hydroxychloroquine
PTF decries continued refusal by hospitals to treat patients for fear of coronavirus
The Presidential Taskforce on COVID-19 (PTF) has decried the continued refusal by medical institutions including federal tertiary institutions to receive and treat patients for fear COVID-19. PTF lamented that this development has resulted in several unfortunate and avoidable fatalities. Meanwhile, the PTF will conclude its assessment on the impact of the measures put in place and further recommendations would be submitted to the President for a decision within the next seventy hours. Chairman of PTF and the Secretary to the Government of the Federation (SGF), Boss Mustapha, who disclosed this at the daily Press Briefing in Abuja, noted that Nigeria is having more deaths from non-attendance to other diseases than even COVID 19 adding that the reason for the greater emphasis on COVID 19 is ...
Hydroxychloroquine Trials for COVID-19 Suspended by WHO
Sourced from Getty Images. The World Health Organization (WHO) announced that it is pausing clinical trials on the use of the controversial malaria drug, hydroxychloroquine, to treat patients with COVID-19. This was one of four experimental treatments being investigated by the organization and has been under intense scrutiny for some time after it was championed by tech mogul Elon Musk and US President Donald Trump. “The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board,” says Tedros Adhanom Ghebreyesus, WHO director-general, during a press briefing. This “Solidarity trial” is the WHO’s global investigation into experimental treatments for COVID-19 – including hyd...
